Large Clinical Trials Change Experts Minds On Prostate Cancer Screening | Latest News RSS feed

Large Clinical Trials Change Experts Minds On Prostate Cancer Screening - Latest News


Large clinical trials change experts’ minds on prostate cancer screening

Prostate cancer screening is now something to consider for men aged 55 to 69, according to the federal panel tasked with making recommendations for such preventative care options. In a finalized recom... read more

ASCO 2017: 4 ways treatment could change following world’s largest cancer conference

Headline grabbing results from 2 large clinical trials showed that offering the prostate cancer drug abiraterone (Zytiga ... medicines for lung cancers with faulty EGFR. Experts said the results could ... read more

Prostate-Cancer Screening: Men Should Forgo PSA Testing, Panel Advises

The USPSTF, which in 2009 recommended that women delay routine mammograms until age 50, based its prostate-cancer-screening guidelines on a review of previous research, including two large studies ... ... read more

Looking for another news?


Men: Are You at Risk for Prostate Health Issues?

Chances of prostate cancer also increase with age. A large prostate does not ... Network recommends baseline PSA screening for healthy men ages 50 to 70 every one to two years, based on the results of ... read more


Overdiagnosis—when finding cancer can do more harm than good

Overdiagnosis is one of the key things to consider when working out the balance of possible benefits and harms of cancer screening. Keep in mind ... A large study from 2013 looked at the results of di... read more

Large Pharma and Small Biotech Deals Expected to Increase in 2010

Andrew Baum, a health care investment analyst from Morgan Stanley, issued a report last week titled "Exit Research and Create Value" advising large pharma companies ... of a professional analyst, neve... read more

New Prostate Cancer Test Shows Greater Accuracy

A new, more accurate test to detect prostate cancer may soon change the way doctors screen ... "It is not ready for routine clinical use, but the results are exciting enough to do large-scale prospect... read more

Implementation of a Performance Improvement Initiative in Colorectal Cancer Care

Purpose: In the United States, colorectal cancer (CRC) is the third leading cause of cancer after breast and prostate cancer ... In addition, research is ongoing to develop new screening tools and inc... read more

Osteoporosis in Men: Undertreated and Overlooked

And screening for ... a physician and senior research scientist at Berkeley Madonna, Inc. in Berkeley, California. "Unique risk factors for men include low testosterone levels and use of androgen depr... read more

Research: Having a Black Doctor Led Black Men to Receive More-Effective Care

They were the most reluctant to have services done in the beginning, and they were the most likely to change their minds after talking to a black doctor and to have more services done. This is meaning... read more

iCAD, Inc. (ICAD) CEO Michael Klein on Q3 2018 Results - Earnings Call Transcript

Our focal therapy approach to prostate cancer can best be described ... with the results from a growing body of additional positive clinical research assessing outcomes of IORT for breast cancer treat... read more



FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us